STEMI management algorithm US Medical PG Practice Questions and MCQs
Practice US Medical PG questions for STEMI management algorithm. These multiple choice questions (MCQs) cover important concepts and help you prepare for your exams.
STEMI management algorithm US Medical PG Question 1: A 58-year-old man comes to the emergency department for complaints of crushing chest pain for 4 hours. He was shoveling snow outside when the pain started. It is rated 7/10 and radiates to his left arm. An electrocardiogram (ECG) demonstrates ST-segment elevation in leads V2-4. He subsequently undergoes percutaneous coronary intervention (PCI) and is discharged with aspirin, clopidogrel, carvedilol, atorvastatin, and lisinopril. Five days later, the patient is brought to the emergency department by his wife with complaints of dizziness. He reports lightheadedness and palpitations for the past 2 hours but otherwise feels fine. His temperature is 99.7°F (37.6°C), blood pressure is 95/55 mmHg, pulse is 105/min, and respirations are 17/min. A pulmonary artery catheter is performed and demonstrates an increase in oxygen concentration at the pulmonary artery. What finding would you expect in this patient?
- A. Widespread ST-segment elevations
- B. Harsh, loud, holosystolic murmur at the lower left sternal border (Correct Answer)
- C. Pulseless electrical activity
- D. Drop of systolic blood pressure by 20 mmHg during inspiration
- E. Normal findings
STEMI management algorithm Explanation: ***Harsh, loud, holosystolic murmur at the lower left sternal border***
- This patient's presentation, including recent **anterior STEMI**, dizziness, lightheadedness, palpitations, hypotension, tachycardia, and **increased oxygen saturation in the pulmonary artery** (oxygen "step-up" indicating a left-to-right shunt), is highly suggestive of **ventricular septal rupture (VSR)**.
- VSR is a **mechanical complication** of MI that typically occurs **3-7 days post-infarction** when the necrotic myocardium is weakest.
- A **VSR** causes a **harsh, loud, holosystolic murmur** best heard at the **lower left sternal border** due to turbulent blood flow through the septal defect from the left ventricle to the right ventricle.
- The left-to-right shunt results in oxygenated blood from the left ventricle mixing with deoxygenated blood in the right ventricle, causing the characteristic oxygen saturation step-up detected by pulmonary artery catheterization.
*Widespread ST-segment elevations*
- Widespread ST-segment elevations are characteristic of **acute pericarditis**, which typically presents with **pleuritic chest pain** that improves when leaning forward and a **friction rub**, not the hemodynamic compromise described here.
- While **Dressler syndrome** (post-MI pericarditis) can occur weeks after MI, the acute hemodynamic instability, left-to-right shunt evidence, and 5-day timeframe point to VSR rather than pericarditis.
*Pulseless electrical activity*
- **Pulseless electrical activity (PEA)** indicates cardiac arrest with organized electrical activity but no mechanical cardiac output, resulting in an **unpalpable pulse**.
- The patient has a documented pulse of **105/min**, which directly contradicts PEA.
- A patient in PEA would be unconscious and unable to report symptoms for 2 hours.
*Drop of systolic blood pressure by 20 mmHg during inspiration*
- A drop in systolic blood pressure >10 mmHg during inspiration (**pulsus paradoxus**) is characteristic of **cardiac tamponade** or severe obstructive airway disease.
- While **free wall rupture** leading to tamponade is another mechanical complication post-MI, the **oxygen saturation step-up** in the pulmonary artery is pathognomonic for an **intracardiac shunt** (VSR), not tamponade.
- Tamponade would show equalization of diastolic pressures across all chambers, not increased PA oxygen saturation.
*Normal findings*
- The patient presents with clear evidence of hemodynamic compromise: **hypotension (95/55 mmHg)**, **tachycardia (105/min)**, dizziness, and lightheadedness.
- The **oxygen saturation step-up** in the pulmonary artery is an objective abnormal finding indicating an intracardiac left-to-right shunt.
- Therefore, normal findings are incompatible with this clinical presentation.
STEMI management algorithm US Medical PG Question 2: Two days after admission for myocardial infarction and subsequent coronary angioplasty, a 65-year-old man becomes distressed and diaphoretic in the cardiac intensive care unit. Suddenly he is no longer responsive. Pulse oximetry does not show a tracing. He has a history of hypertension and depression. Prior to his admission, his medication included ramipril and aripiprazole. Examination shows no carotid pulse. An ECG is shown. After beginning chest compressions, which of the following is the most appropriate step in management of the patient?
- A. Intravenous procainamide
- B. Cardiac catheterization
- C. Intravenous amiodarone
- D. Intravenous magnesium sulfate
- E. Defibrillation (Correct Answer)
STEMI management algorithm Explanation: ***Defibrillation***
- The ECG shows a **wide complex tachycardia** consistent with either **ventricular fibrillation (VF)** or **pulseless ventricular tachycardia (VT)**.
- In a patient who is **unresponsive and pulseless**, both VF and pulseless VT are treated identically with **immediate unsynchronized defibrillation** after initiating CPR, according to **ACLS guidelines**.
- **Defibrillation** is the definitive treatment to restore a perfusing rhythm and is the priority intervention after chest compressions have begun.
*Intravenous procainamide*
- **Procainamide** is an antiarrhythmic drug used for certain types of **stable ventricular tachycardia** or wide-complex tachycardia of uncertain type when the patient has a pulse.
- It is **contraindicated** in pulseless arrhythmias like VF or pulseless VT, where electrical therapy (defibrillation) is paramount.
- Administration would cause dangerous delay in definitive treatment.
*Cardiac catheterization*
- **Cardiac catheterization** is an invasive diagnostic and interventional procedure typically performed to evaluate and treat coronary artery disease.
- It is **not an immediate life-saving intervention** for a patient in **cardiac arrest**, which requires immediate electrical therapy.
- Catheterization may be considered after return of spontaneous circulation (ROSC) to address underlying ischemia.
*Intravenous amiodarone*
- **Amiodarone** is an antiarrhythmic agent used in **VF/pulseless VT that is refractory to initial defibrillation attempts** and after epinephrine administration.
- It is administered **after initial defibrillation attempts have failed**, not as the primary or first-line treatment.
- The ACLS algorithm recommends amiodarone after the third shock if VF/pulseless VT persists.
*Intravenous magnesium sulfate*
- **Magnesium sulfate** is the treatment of choice for **Torsades de Pointes**, a polymorphic ventricular tachycardia often associated with **prolonged QT interval**.
- The clinical presentation and ECG do not suggest Torsades de Pointes, and magnesium is not indicated as the initial treatment for VF or monomorphic VT.
- Magnesium may also be considered for refractory VF/VT with suspected hypomagnesemia.
STEMI management algorithm US Medical PG Question 3: A 54-year-old man is brought to the emergency department 1 hour after the sudden onset of shortness of breath, epigastric pain, and sweating. He has no history of similar symptoms. He has hypertension and type 2 diabetes mellitus. Current medications include amlodipine and metformin. He has smoked one pack of cigarettes daily for 20 years. He appears weak and pale. His pulse is 56/min, respirations are 18/min, and blood pressure is 100/70 mm Hg. Cardiac examination shows normal heart sounds. The lungs are clear to auscultation. The skin is cold to the touch. An ECG is shown. Bedside transthoracic echocardiography shows normal left ventricular function. High-dose aspirin is administered. Administration of which of the following is most appropriate next step in management?
- A. Intravenous atropine
- B. Intravenous morphine
- C. Normal saline bolus (Correct Answer)
- D. Phenylephrine infusion
- E. Sublingual nitroglycerin
STEMI management algorithm Explanation: ***Normal saline bolus***
- This patient presents with symptoms concerning for an inferior wall myocardial infarction (MI) which commonly affects the **right ventricle (RV)**. The ECG shows **ST elevation in leads II, III, and aVF**, confirming an inferior STEMI. Given his **hypotension (100/70 mm Hg)** and **bradycardia (56/min)**, he is likely experiencing RV involvement and is preload-dependent.
- A **normal saline bolus** is crucial to increase preload and improve cardiac output, especially in RV infarcts where reduced preload significantly impairs RV function and, consequently, left ventricular filling.
*Intravenous atropine*
- While the patient has bradycardia, it is secondary to the inferior MI affecting the **right coronary artery**, which often supplies the **AV node**.
- Atropine is used for symptomatic bradycardia but a fluid bolus should be prioritized in RV MI with hypotension to restore preload before considering pharmacologic interventions for heart rate.
*Intravenous morphine*
- Morphine is used for pain relief in acute MI but can cause **vasodilation**, which would worsen this patient's **hypotension**.
- In cases of RV infarction, where preload dependence is critical, morphine should be used with extreme caution or avoided due to its potential to further reduce blood pressure.
*Phenylephrine infusion*
- Phenylephrine is a **pure alpha-agonist** that causes **vasoconstriction** and increases systemic vascular resistance, thereby increasing afterload.
- Increasing afterload in the setting of an acute MI, especially one with potential RV involvement and preload dependence, can severely compromise cardiac function and worsen the patient's condition.
*Sublingual nitroglycerin*
- Nitroglycerin causes **vasodilation**, reducing both preload and afterload.
- In a patient with an **inferior wall MI** and **hypotension**, nitroglycerin is contraindicated as it can profoundly reduce preload, leading to a significant drop in blood pressure and worsening shock, especially if the right ventricle is involved.
STEMI management algorithm US Medical PG Question 4: A 66-year-old man presents to the emergency department with a 3-hour history of crushing chest pain radiating to the left shoulder and neck. Patient states that the pain began suddenly when he was taking a walk around the block and has not improved with rest. He also mentions difficulty breathing and prefers to sit leaning forward. He denies ever having similar symptoms before. Past medical history is significant for hypertension, diagnosed 10 years ago, and hyperlipidemia diagnosed 8 years ago. Current medications are atorvastatin. Patient is also prescribed hydrochlorothiazide as an antihypertensive but is not compliant because he says it makes him urinate too often.
Vitals show a blood pressure of 152/90 mm Hg, pulse of 106/min, respirations of 22/min and oxygen saturation of 97% on room air. On physical exam, patient is profusely diaphoretic and hunched over in distress. Cardiac exam is unremarkable and lungs are clear to auscultation. During your examination, the patient suddenly becomes unresponsive and a pulse cannot be palpated. A stat ECG shows the following (see image). Which of the following is the next best step in management?
- A. Synchronized cardioversion
- B. Administer amiodarone
- C. Urgent echocardiography
- D. Administer epinephrine
- E. Unsynchronized cardioversion (Correct Answer)
STEMI management algorithm Explanation: ***Unsynchronized cardioversion***
- The ECG shows **ventricular fibrillation (VF)**, a chaotic electrical activity with no coordinated contractions, which leads to immediate cardiac arrest.
- In a patient who is unresponsive and pulseless with VF, **immediate unsynchronized defibrillation** (cardioversion) is the definitive treatment to restore a perfusing rhythm.
*Synchronized cardioversion*
- **Synchronized cardioversion** delivers an electrical shock timed to the QRS complex, used for unstable patients with a pulse and organized tachyarrhythmias (e.g., ventricular tachycardia with a pulse, atrial flutter, or atrial fibrillation).
- This patient is **pulseless** and in **ventricular fibrillation**, making synchronized cardioversion inappropriate and ineffective.
*Administer amiodarone*
- **Amiodarone** is an antiarrhythmic drug used in cardiac arrest protocols for **refractory VF/pulseless VT** after initial defibrillation attempts and epinephrine have failed.
- It is not the *initial* best step in a pulseless patient with VF, as electrical defibrillation is paramount.
*Urgent echocardiography*
- While an echocardiogram might be useful in identifying the underlying cause (e.g., myocardial infarction leading to VF), it is **not the immediate life-saving intervention** for a patient in cardiac arrest from VF.
- Delaying defibrillation for an echocardiogram would significantly worsen the patient's prognosis.
*Administer epinephrine*
- **Epinephrine** is a vasoconstrictor and cardiac stimulant used during **cardiac arrest**, typically given after the initial defibrillation attempt for VF/pulseless VT.
- It helps improve myocardial and cerebral blood flow but is **secondary to immediate defibrillation** in VF.
STEMI management algorithm US Medical PG Question 5: A 57-year-old man presents to the emergency department for evaluation of slurred speech and left arm and leg weakness over the last 3 hours. History reveals hypertension that is being treated with hydrochlorothiazide. Vital signs include: blood pressure of 110/70 mm Hg, heart rate 104/min, respiratory rate 18/min, and temperature 36.6°C (98.0°F). Physical examination reveals 2/5 strength in both left upper and lower extremities. After 2 hours, the patient’s symptoms suddenly disappear. An electrocardiogram (ECG) is obtained (see image). Which of the following medications could prevent ischemic attacks in this patient in the future?
- A. Warfarin (Correct Answer)
- B. Acetylsalicylic acid
- C. Enoxaparin
- D. Heparin
- E. Clopidogrel
STEMI management algorithm Explanation: ***Warfarin***
- The patient experienced a **transient ischemic attack (TIA)** due to the sudden onset of neurological symptoms that resolved completely. The ECG shows **atrial fibrillation (AFib)**, characterized by an irregularly irregular rhythm and absence of P waves, which is a significant risk factor for cardioembolic stroke.
- **Oral anticoagulation** is essential for preventing ischemic stroke in patients with AFib. While **direct oral anticoagulants (DOACs)** such as apixaban, rivaroxaban, or dabigatran are now preferred as first-line therapy per current guidelines, **warfarin** remains an effective alternative and is the only oral anticoagulant option listed here.
- Warfarin prevents the formation of blood clots in the heart chambers by inhibiting vitamin K-dependent clotting factors, thereby reducing the risk of cardioembolic stroke.
*Acetylsalicylic acid*
- **Aspirin (acetylsalicylic acid)** is an antiplatelet agent used for primary and secondary prevention of ischemic stroke, particularly in patients with non-cardioembolic causes.
- While aspirin can be used in some cases, its efficacy in preventing stroke in patients with AFib is **significantly lower than that of oral anticoagulants** like warfarin or DOACs (reduces stroke risk by ~20% vs ~60-70% with anticoagulation).
*Enoxaparin*
- **Enoxaparin** is a low molecular weight heparin, an anticoagulant typically used for the **acute treatment** of deep vein thrombosis (DVT) and pulmonary embolism (PE), and sometimes as a bridge to warfarin therapy.
- It is not routinely used for **long-term prevention** of ischemic stroke in patients with AFib due to its parenteral (subcutaneous) administration and the need for daily injections.
*Heparin*
- **Heparin** (unfractionated) is an anticoagulant used for acute management of thrombotic events but requires continuous intravenous infusion and close monitoring of aPTT.
- Similar to enoxaparin, it is not practical or recommended for **long-term outpatient prophylaxis** against stroke in AFib.
*Clopidogrel*
- **Clopidogrel** is an antiplatelet agent that inhibits platelet aggregation via P2Y12 receptor blockade and is used in patients with atherosclerotic disease or as an alternative to aspirin in certain circumstances.
- It works by a different mechanism than anticoagulants and is generally **less effective than warfarin or DOACs** for preventing cardioembolic stroke from AFib (similar efficacy to aspirin alone).
STEMI management algorithm US Medical PG Question 6: A 54-year-old woman comes to the emergency department because of two episodes of bright red blood per rectum within the past day. She has a history of migraine, which is treated prophylactically with verapamil. She appears well and is hemodynamically stable. Cardiac exam reveals a regular heart rate without any murmurs or gallops. Lungs are clear to auscultation. Her abdomen is mildly tender without rebound or guarding. Digital rectal examination shows fresh blood on the glove. Laboratory studies show:
Hemoglobin 10.4 g/dL
Leukocyte count 5,000/mm3
Platelet count 175,000/mm3
Partial thromboplastin time 35 seconds
Serum
Na+ 140 mEq/L
K+ 3.7 mEq/L
Cl- 101 mEq/L
HCO3- 25 mEq/L
Mg2+ 1.8 mEq/L
A routine ECG shows a heart rate of 75/min, a normal axis, PR interval of 280 ms, QRS interval of 80 ms with a QRS complex following each p wave, and no evidence of ischemic changes. Which of the following is the most appropriate next step in management with respect to this patient's cardiovascular workup?
- A. Observation (Correct Answer)
- B. Atropine therapy
- C. Synchronized cardioversion
- D. Metoprolol therapy
- E. Pacemaker placement
STEMI management algorithm Explanation: ***Observation***
- The patient is currently **hemodynamically stable** despite the prolonged PR interval, indicating that the **first-degree AV block** is not causing immediate compromise.
- Continuation of **verapamil** (a calcium channel blocker) for migraine prophylaxis is the likely cause of the prolonged PR interval; however, in the absence of symptoms attributable to the AV block, observation is appropriate.
*Atropine therapy*
- **Atropine** is used to increase heart rate in **symptomatic bradycardia** or higher-degree AV blocks (second or third-degree) if the patient is unstable.
- This patient is **hemodynamically stable** with a heart rate of 75/min and has only a first-degree AV block, making atropine unnecessary.
*Synchronized cardioversion*
- **Synchronized cardioversion** is reserved for **unstable tachyarrhythmias** or some unstable bradyarrhythmias not responsive to chemical therapy.
- The patient's heart rate is 75/min, and she has **no evidence of an arrhythmia** requiring cardioversion; her prolonged PR interval is a conduction delay, not an arrhythmia.
*Metoprolol therapy*
- **Metoprolol** is a beta-blocker that would **further slow AV nodal conduction** and could potentially worsen the first-degree AV block or precipitate a higher-degree block.
- It is contraindicated as a treatment for AV block and would exacerbate the underlying issue caused by verapamil.
*Pacemaker placement*
- **Pacemaker placement** is considered for **symptomatic second-degree or third-degree AV block**, or in some cases of first-degree AV block if it progresses to a higher degree and causes severe symptoms.
- This patient has a **first-degree AV block** and is **asymptomatic** and **hemodynamically stable**, thus a pacemaker is not indicated at this time.
STEMI management algorithm US Medical PG Question 7: A 55-year-old man comes to the emergency department because of left-sided chest pain and difficulty breathing for the past 30 minutes. His pulse is 88/min. He is pale and anxious. Serum studies show increased cardiac enzymes. An ECG shows ST-elevations in leads I, aVL, and V5-V6. A percutaneous coronary intervention is performed. In order to localize the site of the lesion, the catheter must pass through which of the following structures?
- A. Left coronary artery → left circumflex artery (Correct Answer)
- B. Right coronary artery → posterior descending artery
- C. Left coronary artery → left anterior descending artery
- D. Right coronary artery → right marginal artery
- E. Left coronary artery → posterior descending artery
STEMI management algorithm Explanation: ***Left coronary artery → left circumflex artery***
- **ST-elevations** in leads I, aVL, and V5-V6 are indicative of a **lateral myocardial infarction**.
- The **left circumflex artery** primarily supplies the lateral wall of the left ventricle.
*Right coronary artery → posterior descending artery*
- The **posterior descending artery** (PDA) typically supplies the inferior wall and posterior interventricular septum.
- An occlusion here would cause **ST-elevations** in leads II, III, and aVF, which is not seen in this case.
*Left coronary artery → left anterior descending artery*
- The **left anterior descending** (LAD) artery supplies the anterior wall and apex of the left ventricle.
- Occlusion of the LAD would typically cause **ST-elevations** in leads V1-V4, indicating an anterior MI.
*Right coronary artery → right marginal artery*
- The **right marginal artery** is a branch of the right coronary artery and supplies part of the right ventricle.
- Occlusion here would primarily affect the **right ventricle**, and is not typically associated with the given ECG changes.
*Left coronary artery → posterior descending artery*
- While the **posterior descending artery** can sometimes originate from the left circumflex artery (**left dominant circulation**), it primarily supplies the inferior wall.
- The observed ECG changes in leads I, aVL, and V5-V6 are characteristic of a **lateral wall infarct**, which is supplied by the left circumflex artery.
STEMI management algorithm US Medical PG Question 8: A 60-year-old man presents to the emergency department with progressive dyspnea for the last 3 weeks. He complains of shortness of breath while lying flat and reports nighttime awakenings due to shortness of breath for the same duration. The patient has been a smoker for the last 30 years. Past medical history is significant for myocardial infarction 7 months ago. Current medications include metoprolol, aspirin, and rosuvastatin, but the patient is noncompliant with his medications. His temperature is 37.2°C (98.9°F), the blood pressure is 150/115 mm Hg, the pulse is 110/min, and the respiratory rate is 24/min. Oxygen saturation on room air is 88%. Chest auscultation reveals bilateral crackles and an S3 gallop. On physical examination, the cardiac apex is palpated in left 6th intercostal space. Bilateral pitting edema is present, and the patient is in moderate distress. Which of the following is the best next step in the management of the patient?
- A. Intravenous beta blockers
- B. Intravenous diuretics (Correct Answer)
- C. Echocardiography
- D. Cardiac stress testing
- E. Intravenous inotropes
STEMI management algorithm Explanation: ***Intravenous diuretics***
- The patient presents with classic signs and symptoms of **acute decompensated heart failure**, such as progressive dyspnea, orthopnea, paroxysmal nocturnal dyspnea, bilateral crackles, S3 gallop, pitting edema, and elevated blood pressure with elevated heart rate due to fluid overload.
- **Intravenous loop diuretics** (e.g., furosemide) are the most appropriate initial therapy to reduce preload, alleviate pulmonary and systemic congestion, and improve oxygenation.
*Intravenous beta blockers*
- While beta-blockers are a cornerstone of chronic heart failure management, **starting or acutely increasing beta-blocker dosage in acute decompensated heart failure** can worsen cardiac output and lead to symptomatic hypotension or cardiogenic shock.
- Beta-blockers should generally be withheld or reduced during acute exacerbations and reinstituted once the patient is stable.
*Echocardiography*
- While an **echocardiogram** is essential for diagnosing the underlying cause and assessing cardiac function in heart failure, it is not the *best next step* in a patient presenting with acute, severe symptoms requiring immediate stabilization.
- The patient's acute respiratory distress and hypoxemia necessitate immediate medical intervention to reduce fluid overload before detailed diagnostic imaging.
*Cardiac stress testing*
- **Cardiac stress testing** is used to evaluate for inducible ischemia in stable patients and is not appropriate in the setting of acute decompensated heart failure.
- Performing a stress test on a patient with signs of fluid overload and respiratory distress would be dangerous and could exacerbate their condition.
*Intravenous inotropes*
- **Intravenous inotropes** (e.g., dobutamine, milrinone) are typically reserved for patients with evidence of **cardiogenic shock** or severe heart failure with persistent hypoperfusion despite optimal fluid management and diuretic therapy.
- This patient, while acutely ill, primarily exhibits signs of fluid overload without clear evidence of severe hypoperfusion compromising end-organ function.
STEMI management algorithm US Medical PG Question 9: A 70-year-old man with diabetes, hypertension, and chronic kidney disease (eGFR 35 mL/min/1.73m²) presents with NSTEMI. Troponin is elevated at 8.5 ng/mL. ECG shows 2mm ST depression in V2-V5. GRACE score is 165 (high risk). He is hemodynamically stable. Cardiologist recommends early invasive strategy within 24 hours. Nephrologist is concerned about contrast-induced nephropathy potentially requiring dialysis. Patient is on metformin. Evaluate the management strategy integrating multiple specialist perspectives and evidence.
- A. Proceed with angiography within 24 hours using iso-osmolar contrast and intravenous hydration, hold metformin (Correct Answer)
- B. Perform coronary CT angiography as alternative to invasive angiography
- C. Delay catheterization for 72 hours to optimize renal function with hydration
- D. Prophylactic hemodialysis before and after catheterization to remove contrast
- E. Medical management only with dual antiplatelet therapy, avoid catheterization
STEMI management algorithm Explanation: ***Proceed with angiography within 24 hours using iso-osmolar contrast and intravenous hydration, hold metformin***
- High-risk NSTEMI patients with a **GRACE score >140** benefit from an **early invasive strategy** within 24 hours to reduce ischemic events and mortality.
- Renal protection is maximized through **pre-procedural hydration** and **iso-osmolar contrast**, while **metformin** must be held to avoid the risk of lactic acidosis if acute kidney injury occurs.
*Perform coronary CT angiography as alternative to invasive angiography*
- **Coronary CTA** is primarily used for ruling out coronary artery disease in low-to-intermediate risk stable patients, not for high-risk **NSTEMI**.
- This modality still requires **iodinated contrast** and does not provide the therapeutic benefit of percutaneous coronary intervention (**PCI**).
*Delay catheterization for 72 hours to optimize renal function with hydration*
- Delaying the procedure in a high-risk patient increases the risk of **re-infarction** and **cardiovascular death**, outweighing the minor benefits of prolonged hydration.
- Evidence suggests that optimization of renal status should happen concurrently with the preparation for **early intervention** in high-risk ACS.
*Prophylactic hemodialysis before and after catheterization to remove contrast*
- **Prophylactic hemodialysis** has not been proven to prevent contrast-induced nephropathy and may actually increase the risk of adverse events.
- High-volume **intravenous hydration** with isotonic saline remains the gold standard for preventing renal injury in patients with **CKD**.
*Medical management only with dual antiplatelet therapy, avoid catheterization*
- While **dual antiplatelet therapy** is essential, medical management alone is inferior to an invasive strategy in patients with **high GRACE scores**.
- Avoiding catheterization based solely on **renal impairment** results in "renalism," where patients are undertreated for their life-threatening cardiac condition.
STEMI management algorithm US Medical PG Question 10: A 58-year-old woman with anterior STEMI underwent primary PCI with drug-eluting stent placement. Post-procedure echocardiogram shows left ventricular ejection fraction of 30% with apical akinesis. She is started on aspirin, ticagrelor, high-intensity statin, and ACE inhibitor. On hospital day 3, she develops atrial fibrillation with rapid ventricular response. CHA2DS2-VASc score is 4. Creatinine is normal. Evaluate the optimal antithrombotic strategy balancing ischemic and bleeding risk.
- A. Triple therapy with aspirin, ticagrelor, and apixaban indefinitely
- B. Triple therapy for 6 months, then aspirin and apixaban indefinitely
- C. Aspirin and ticagrelor only, hold anticoagulation due to bleeding risk
- D. Warfarin with INR 2-3 plus aspirin, discontinue ticagrelor
- E. Triple therapy for 1 month, then apixaban and clopidogrel for 11 months, then apixaban alone (Correct Answer)
STEMI management algorithm Explanation: ***Triple therapy for 1 month, then apixaban and clopidogrel for 11 months, then apixaban alone***
- In patients with **Atrial Fibrillation** (CHA2DS2-VASc ≥2) undergoing **PCI**, current guidelines recommend minimizing the duration of **triple therapy** (aspirin, P2Y12 inhibitor, and anticoagulant) to 1 week to 1 month to reduce **bleeding risk**.
- Transitioning to **dual therapy** with a **NOAC** (like apixaban) and a P2Y12 inhibitor (preferably **clopidogrel**) for up to 12 months, followed by NOAC monotherapy, provides an optimal balance between preventing **stent thrombosis** and systemic **thromboembolism**.
*Triple therapy with aspirin, ticagrelor, and apixaban indefinitely*
- Indefinite **triple therapy** carries a prohibitively high risk of life-threatening **major bleeding** without added benefit for stroke prevention.
- **Ticagrelor** is generally avoided in triple therapy regimens due to a significantly higher bleeding profile compared to **clopidogrel**.
*Triple therapy for 6 months, then aspirin and apixaban indefinitely*
- **Triple therapy** for 6 months is rarely indicated and significantly increases the risk of **gastrointestinal and intracranial hemorrhage** compared to the 1-month strategy.
- Aspirin is usually discontinued after the first year in favor of **anticoagulant monotherapy**, as the latter is sufficient for both AF and stable CAD protection.
*Aspirin and ticagrelor only, hold anticoagulation due to bleeding risk*
- This approach leaves the patient with a high **CHA2DS2-VASc score of 4** unprotected against **cardioembolic stroke**, which carries high morbidity and mortality.
- Dual antiplatelet therapy (DAPT) alone is significantly less effective than **oral anticoagulants** for stroke prevention in the setting of atrial fibrillation.
*Warfarin with INR 2-3 plus aspirin, discontinue ticagrelor*
- **NOACs** (like apixaban) are now preferred over **Warfarin** for non-valvular AF due to a superior safety profile, including a lower risk of **intracranial hemorrhage**.
- Discontinuing the P2Y12 inhibitor (ticagrelor) immediately post-PCI in favor of aspirin and warfarin significantly increases the risk of **stent thrombosis**.
More STEMI management algorithm US Medical PG questions available in the OnCourse app. Practice MCQs, flashcards, and get detailed explanations.
